These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9809407)

  • 1. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
    Engel PM; Dennin RH
    Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.
    Dussaix E; Charnaux N; Laurent-Puig P; Chopineau S; Laurian Y; Buffet C
    J Clin Microbiol; 1994 Sep; 32(9):2071-5. PubMed ID: 7529247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA.
    de Medina M; Hill M; Sullivan HO; Leclerq B; Pennell JP; Jeffers L; Reddy KR; Schiff ER; Perez GO
    J Lab Clin Med; 1998 Jul; 132(1):73-5. PubMed ID: 9665375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes.
    Zein NN; Germer JJ; Wendt NK; Schimek CM; Thorvilson JN; Mitchell PS; Persing DH
    J Clin Microbiol; 1997 Jan; 35(1):311-2. PubMed ID: 8968936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay.
    Buffet C; Charnaux N; Laurent-Puig P; Chopineau S; Quichon JP; Briantais MJ; Dussaix E
    J Med Virol; 1994 Jul; 43(3):259-61. PubMed ID: 7523581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on reliability of commercially available hepatitis C virus antibody tests.
    Feucht HH; Zöllner B; Polywka S; Laufs R
    J Clin Microbiol; 1995 Mar; 33(3):620-4. PubMed ID: 7751366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
    Kiely P; Kay D; Parker S; Piscitelli L
    Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
    Pereira FM; Zarife MA; Reis EA; G Reis M
    Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
    Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
    J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
    Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
    Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
    Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
    Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological diagnosis of hepatitis C virus in patients with liver disease in Saudi Arabia. Evaluation of antibody determination by recombinant immunoblot assays in relation to RNA detection by polymerase chain reaction.
    Al-Ahdal MN; Kessie G
    Diagn Microbiol Infect Dis; 1997 Mar; 27(3):69-73. PubMed ID: 9147007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients.
    Bresters D; Zaaijer HL; Cuypers HT; Reesink HW; Winkel IN; van Exel-Oehlers PJ; van Drimmelen AA; Jansen PL; van der Poel CL; Lelie PN
    Transfusion; 1993 Aug; 33(8):634-8. PubMed ID: 7688158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
    Bååth L; Widell A; Nordenfelt E
    J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
    Cavazza S; Lagging M
    Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hepatitis C virus infection with recombinant immunoblot assay, synthetic immunoblot assay, and polymerase chain reaction.
    Chaudhary RK; Andonov A; MacLean C
    J Clin Lab Anal; 1993; 7(3):164-7. PubMed ID: 7685380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
    Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
    Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus antibody prevalence among human immunodeficiency virus-1-infected individuals: analysis with different test systems.
    Nübling CM; von Wangenheim G; Staszewski S; Löwer J
    J Med Virol; 1994 Sep; 44(1):49-53. PubMed ID: 7798885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for the detection and confirmation of antibodies to hepatitis C virus in dried blood spots.
    Parker SP; Cubitt WD; Ades AE
    J Virol Methods; 1997 Nov; 68(2):199-205. PubMed ID: 9389410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.